Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease

NCT03196375 is registered in ClinicalTrials.gov with Flex Pharma, Inc. as lead sponsor.

NCT NCT03196375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03196375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Motor Neuron Disease
Lead sponsor
Flex Pharma, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
July 28, 2017
Completion date
July 27, 2018
Enrollment
54 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

motor neuron disease